FDA Inspection 1168570 — Oklahoma Blood Institute Texas Blood Institute

Oklahoma Blood Institute Texas Blood Institute — FEI 3006605544

The FDA completed an inspection of Oklahoma Blood Institute Texas Blood Institute on April 22, 2022 in Wichita Falls, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 22, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Wichita Falls, TX (United States)